April 4 (Reuters) - Johnson & Johnson ( JNJ ) said on

Thursday it has recommended its shareholders to reject an

unsolicited "mini-tender" offer by TRC Capital Investment

Corporation for about 0.04% of its common stock.

The drugmaker said Ontario-based TRC Capital has offered to

purchase up to 1 million shares of J&J's stock at a price of

$151.23 per share in cash.